latest news releases from the newsroom
CEVA Licenses CEVA-X DSP Architecture to Korea's EoNex to Power 3G Wireless Solutions
SAN JOSE, Calif. and KYUNGGI-DO, Korea, April 19, 2004 (PRIMEZONE) -- CEVA, Inc. (Nasdaq:CEVA) (LSE:CVA), the leading licensor of Digital Signal Processor (DSP) cores and communications solutions, and EoNex Technologies, Inc., a leading Korean mobile solution provider, today announced that EoNex has selected CEVA's new generation CEVA-X architecture to power their next generation enhanced mobile solutions.
Tele2 Launches Fixed Line Operations in Hungary
NEW YORK and STOCKHOLM, Sweden, April 19, 2004 (PRIMEZONE) ---- Tele2 AB, ("Tele2") (Nasdaq:TLTOA) (Nasfaq:TLTOB) (Stockholmsborsen: TEL2A and TEL2B) the leading alternative pan-European telecommunications company, is pleased to announce the launch of residential fixed line services in Hungary.
Song Networks Holding
Swedish Civil Aviation Administration is new Song Networks customer
STOCKHOLM, Sweden, April 19, 2004 (PRIMEZONE) -- Song Networks Holding AB's (Stockholmsborsen: SONW) Swedish subsidiary Song Networks Svenska AB has signed an agreement with the Swedish Civil Aviation Administration for delivery of directly connected telephony. The new business transaction was concluded following a sub-order from the Swedish Agency for Public Management agreement in which Song Networks offered the best combination of high operational reliability and a low price. The agreement runs for 2 years, with an option to extend it for a further year and has a total value of SEK 14,2 million.
Saab Wins US Army Training Contract Worth USD 14 million
LINKOPING, Sweden, April 19, 2004 (PRIMEZONE) -- Saab Training Systems AB of Huskvarna, Sweden was awarded a firm fixed price contract for $14M to deliver six instrumentation systems by the US Army Program Executive Office for Simulation, Training and Instrumentation (PEO STRI).
Maxim Pharmaceuticals Presents Preclinical Data on Histamine's Ability to Prevent Liver Damage
SAN DIEGO, April 19, 2004 - Maxim Pharmaceuticals (Nasdaq:MAXM) (SSE:MAXM) announced preclinical results indicating that histamine may prevent lipopolysaccharide (LPS)-induced liver injury. The results were presented at the 39th annual European Association for the Study of the Liver (EASL) meeting in Berlin, Germany. In this preclinical study, LPS is used to increase the severity of alcohol-induced damage. These new results demonstrate the ability of histamine to prevent LPS-induced liver injury in a rodent model by showing efficacy when delivered in a manner mimicking oral administration.
US Army Purchases Anti-Armour Weapon from Saab
LINKOPING, Sweden, April 19, 2004 (PRIMEZONE) -- The US Army has placed a first order for the AT4 CS anti-armour weapon with Saab Bofors Dynamics in Karlskoga. The order has been preceded by an extensive United States Special Operations Command (USSOCOM) qualification, which lasted throughout 2003.